Growth Investments

Target companies have typically moved past early product refinement, with annual revenue in the tens to hundreds of millions of RMB and a clear growth curve that has not yet leveled into maturity. A complete management team with founders still actively operating the business is a general precondition. Industries concentrate in enterprise software, financial technology infrastructure, consumer brands and healthcare — sectors with a legible expansion path, where the common bottleneck is the capital intensity required for channel expansion, capacity building or replication across regions.

These dimensions are the platform's general investment criteria made specific to the growth stage: unit economics, for instance, concerns the quality of revenue rather than its rate of increase; management team depth concerns whether a second tier exists beyond the founder capable of taking on functional responsibility. The complete criteria framework is set out on the investment criteria page and is not repeated here.

Opportunities mainly arise from ongoing sector coverage: the research team maintains continuous tracking of enterprise software, financial technology, consumer and healthcare tracks to identify companies at an inflection point in their expansion. Direct referrals among management teams matter just as much — many transactions originate from introductions by founders of existing portfolio companies or executives elsewhere in an industry. Financial advisors and intermediaries play a matchmaking role in some transactions, but direct relationships remain the primary source of opportunity for this strategy.

Analysis of growth opportunities follows the common investment process, though the pace is typically faster, since a competitive financing environment requires reaching a judgment within a reasonable window. The analytical emphasis falls on the sustainability of growth and the efficiency of capital use, rather than historical financial performance alone. All transactions are ultimately reviewed and decided by the investment committee under the established process.

Capital is deployed predominantly as minority equity, with most transactions structured as common or preferred shares carrying limited preferential rights, depending on the company's valuation stage and existing shareholder structure. Staged capital release tied to defined operating milestones is common, both protecting capital and giving the company clear execution expectations. Control remains with the founding team throughout; Havrion Capital participates in governance through board representation and information rights rather than through a controlling stake.

Following investment, monitoring centers on agreed operating metrics and milestones, with a board rhythm typically tighter than for control-oriented investments, since execution risk shifts faster during an expansion phase. Havrion Capital supports governance formalization, key management hiring and cross-regional replication experience, but deliberately stays out of product and market decisions, which remain the founding team's responsibility throughout.

The long-term objective is to help a validated business model safely cross the expansion phase and reach a scale capable of securing further financing independently or achieving profitability on its own. Most investments conclude with a staged exit once the company becomes a well-established participant in its industry, or transition into a longer-term holding arrangement, with the specific path determined jointly by the company and its shareholders.